Zhejiang Hisun Pharmaceutical Co Ltd (shse:600267) Share Price

Company Profile

Business description
Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.
Contact
No. 46 Waisha Road
Jiaojiang District
Zhejiang Province
Taizhou318000
CHN
T: +86 4001180618
http://www.hisunpharm.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
7,994

Recommended

We raise our risk and uncertainty rating to reflect the impact of the ruling.

Esther Holloway | 13 July 2025

Shares of the semiconductor giant have rocketed 280% over the past two years amid the AI boom.

Sarah Hansen | 10 July 2025

Platinum’s board voted unanimously in favour of a merger we expect would be value accretive.

Shaun Ler | 10 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,815.30	5.00	-0.06%
CAC 40	7,789.41	39.88	-0.51%
DAX 40	24,083.55	171.76	-0.71%
Dow JONES (US)	44,371.51	279.13	-0.63%
FTSE 100	8,972.76	31.64	0.35%
HKSE	24,203.32	63.75	0.26%
NASDAQ	20,585.53	45.14	-0.22%
Nikkei 225	39,459.62	110.06	-0.28%
NZX 50 Index	12,678.69	7.99	-0.06%
S&P 500	6,259.75	20.71	-0.33%
S&P/ASX 200	8,570.40	9.70	-0.11%
SSE Composite Index	3,519.65	9.47	0.27%